M Potmĕsil - Concepedia

Author

M Potmĕsil

Also Known As

M POTMESIL, M Potmesil, M Potmĕsil, M. Potmesil, MILAN POTMESIL, Milan Potmesil, Milan Potměšil, Potmesil, M, Potmesil, Milan

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

New York University Johns Hopkins University New York City Health and Hospitals Corporation University School University of Applied Sciences and Arts of Southern Switzerland

About

M Potmĕsil is an author at New York University specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	31	2.7K
2	Natural Sciences	8	8	730
3	Health Sciences	3	3	43
4	Engineering	1	1	72
5	Allergy	1	1	96

M Potmĕsil

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
DNA Topoisomerase I—Targeted Chemotherapy of Human Colon Cancer in Xenografts Beppino C. Giovanella, John S. Stehlin, Monroe E. Wall, Science Tumor BiologyGastrointestinal OncologyHuman Colon CancerMedicinePharmacology	1989	645
p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression Soumaya El Rouby, Alexander S. Thomas, Dan Costin, Blood	1993	365
DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues. Y H Hsiang, Leroy F. Liu, Monroe E. Wall, PubMed Hematological MalignancyTumor BiologyMedicinal ChemistryPurified TopoisomeraseL1210 Leukemia	1989	341
Camptothecins: from bench research to hospital wards. M Potmĕsil PubMed MedicineAntibiotic AdjuvantPharmacotherapyBench Research	1994	312
Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance. Alexander S. Thomas, Soumaya El Rouby, John C. Reed, PubMed	1996	273
DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA. Annette L. Bodley, Leroy F. Liu, Mervyn Israel, PubMed Bioorganic ChemistryChemoprevention StrategyDaunorubicin CongenersMolecular BiologyInhibit Intercalation	1989	230
Complete growth inhibition of human cancer xenografts in nude mice by treatment with 20-(S)-camptothecin. B C Giovanella, Hellmuth R. Hinz, Anthony J. Kozielski, PubMed Plant AlkaloidComplete Growth InhibitionPathologyCell ProliferationPharmacotherapy	1991	178
Resistance of human leukemic and normal lymphocytes to drug-induced DNA cleavage and low levels of DNA topoisomerase II. M Potmĕsil, Y H Hsiang, Leroy F. Liu, PubMed Dna DamageImmunotoxicologyImmunologyImmunophenotypingCll Patients	1988	162
Camptothecin overcomes MDR1-mediated resistance in human KB carcinoma cells. A Y Chen, Chiang Yu, M Potmĕsil, PubMed Tumor BiologyDrug SelectivityMdr1 OverexpressionMdr1-mediated ResistanceChemoprevention Strategy	1991	157
Antiangiogenic effects of camptothecin analogues 9-amino-20(S)-camptothecin, topotecan, and CPT-11 studied in the mouse cornea model. James J. O’Leary, Richard L. Shapiro, Chris J. Ren, PubMed Antiangiogenic EffectsPathologyMouse Cornea ModelOcular Surface PhysiologyTumor Biology	1999	96

Page 1